Table 2.

CGM Data by study group

	CGM Group (n=47)	POC Group (n=50)	P-value
Mean daily glucose by CGM, mg/dL	185.15 ± 44.08	191.02 ± 47.25	0.72
Mean daily glucose by POC, mg/dL	175.76 ± 41.79	167.26 ± 47.84	0.19
Mean nocturnal glucose by CGM, mg/dL	176.34 ± 44.56	181.91 ± 47.03	0.68
TIR 70–180 mg/dL, %	53.38 ± 30.16	48.81 ± 28.03	0.40
TAR >180 mg/dL, %	45.79 ± 30.74	49.13 ± 28.11	0.55
TAR >250 mg/dL, %	16.45 ± 19.27	17.80 ± 22.84	0.97
TBR < 70 mg/dL, %	0.83 ± 2.59	1.18 ± 3.54	0.51
TBR < 54 mg/dL, %	0.23 ± 0.85	0.56 ± 2.24	0.88
GV, MAGE	64.03 ± 27.47	62.17 ± 24.02	0.91
GV, SD	45.33 ± 15.35	47.59 ± 15.52	0.44
GV, CV	0.25 ± 0.06	0.25 ± 0.06	0.62
Nocturnal glucose < 70 mg/dL by CGM, %	0.28 ± 1.17	0.73 ± 2.43	0.75
Nocturnal glucose < 54 mg/dL by CGM, %	0.10 ± 0.42	0.33 ± 1.58	0.50
Glucose > 180 mg/dL among participants with hyperglycemia >180 mg/dL by CGM, %	45.79 ± 30.74	50.13 ± 27.48	0.43
Glucose > 250 mg/dL among participants with hyperglycemia >250 mg/dL by CGM, %	20.89 ± 19.47	23.42 ± 23.58	0.68
Glucose < 70 mg/dL among participants with hyperglycemia <70 mg/dL by CGM, %	1.77 ± 3.60	3.45 ± 5.47	0.64
Glucose < 54 mg/dL among participants with hyperglycemia <54 mg/dL by CGM, %	0.99 ± 1.59	3.06 ± 4.71	0.49
Number of days on CGM, Median (Q1, Q3)	17.0 (12, 36)	18.5 (10, 28)	0.74

GV: glycemic variability; MAGE: mean amplitude of glucose excursion; STD: standard deviation; CV: coefficient of variation